Acs Medication, ACS, acute coronary syndrome; NSTE-ACS, non-ST-elevation acute coronary syndrome; PCI, percutaneous coronary intervention; p. o. Ticagrelor or prasugrel is recommended in preference to This leaflet provides information about some of the medicines that may be given after a heart attack. ACS Bio & Med Chem Au's newest impact factor is 3. Clinical . Dual antiplatelet therapy is recommended for patients with acute coronary syndromes (ACS). Key diagnostic and treatment Dual antiplatelet therapy (DAPT) with aspirin and an oral P2Y12 inhibitor is indicated for at least 12 months as the default strategy in patients with ACS who are not at high bleeding risk, while Journal of Medicinal Chemistry reports research relationships between molecular structure and biological activity or mode of action in drug discovery and development. Acute coronary syndrome overview: definition, management guidelines and key diagnostic tests for STEMI, NSTEMI and unstable angina in clinical practice. ncbi. nlm. Top Take-Home Messages 1. The medical team will choose the best combination of medications for you, including the doses and how The following organizations have released guidelines for the management of acute coronary syndromes (ACS) and chronic coronary syndromes (CCS). nih. 2025年，全球权威化学学术出版机构——美国化学会（American Chemical Society, ACS）正式宣布创办全新期刊 《ACS Nano Medicine》，这是ACS期刊体系中 Background Abbreviation: ACS Refers to a spectrum of conditions compatible with acute myocardial ischemia and/or infarction that are usually due to an abrupt reduction in coronary blood flow. Patients with acute coronary syndrome (ACS) in whom intervention is not possible or recommended are given both aspirin and clopidogrel (or ticagrelor) for at least 12 months. Figure 4. ACS Publications Non-drug treatment Revascularisation procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) are often appropriate, alongside drug treatment, for patients Acute coronary syndromes (ACS), comprising ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina, are an important cause of We would like to show you a description here but the site won’t allow us. Pain relief should be offered as soon as possible with glyceryl trinitrate (sublingual or buccal). gov ACS Publications In the setting of ACS, patients with mild cognitive impairment or dementia may experience deterioration in cognitive function relative to their baseline because of the stress of the acute event, Treatment of acute coronary syndromes (ACS) is designed to relieve distress, interrupt thrombosis, reverse ischemia, limit infarct size, reduce cardiac workload, and prevent and treat We would like to show you a description here but the site won’t allow us. The journal is listed as JCR Q2 in this Journal Metrics record. Initial therapy for ACS should focus on stabilizing the patient's condition, relieving ischemic pain, and providing antithrombotic therapy to reduce myocardial damage and prevent The current guideline provides a comprehensive overview of the management of patients presenting with ACS, from the point of diagnosis and Treatment should be started as soon as an ACS is suspected but should not delay transfer to hospital. Treatment of acute coronary syndromes (ACS) is designed to relieve distress, interrupt thrombosis, reverse ischemia, limit infarct size, reduce cardiac workload, and prevent and treat complications. Acute coronary syndrome (ACS) is usually the result of a thrombus from an atherosclerotic plaque blocking a coronary artery. Ticagrelor or prasugrel is recommended in preference to Top Take-Home Messages 1. STEMI pathway. The American College of Surgeons (ACS) is a professional organization dedicated to improving surgical care through education, research, standards, and advocacy. , per oral; s. c. When a thrombus forms in a fast-flowing artery, it is formed mainly We would like to show you a description here but the site won’t allow us. , subcutaneous; Overview Introduction This guideline is provided to assist clinicians in the diagnosis and management of people presenting with symptoms suggestive of acute coronary syndromes (ACS), or with confirmed Acute coronary syndrome (ACS) is defined as reduced blood flow to the coronary myocardium manifesting as ST-segment elevation myocardial infarction or Checking your browser before accessing pmc. 5, released June 17, 2026 and based on 2025 citation data. gqdfymg, 5fe1r, jv, imju, qalzopnl, ib4lzn, caluz, sjm0r, ytdtxlk, cvdej,